Connecticut Innovations Invests $10.2 Million in Third Quarter
Investments leverage $56.4 million in outside capital in fiscal Q3 FY2019
Rocky Hill, Conn. – May 3, 2019 – Connecticut Innovations (CI), Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for the state’s innovative, growing companies, today announced that it invested $10.2 million in 30 unique companies and scientific projects during the three months ended March 31, 2019. The Q3 investments leveraged an additional $56.4 million in capital to further support the growth of these companies.
Of the $10.2 million, CI invested $6.9 million in bioscience and healthcare IT, $3.2 million in information technology and just over $105,000 in other technologies.
“In the third quarter, Connecticut Innovations continued investing in promising startup companies in bioscience, healthcare and IT-related fields across the state,” said David Wurzer, executive vice president and chief investment officer at Connecticut Innovations. “As either a lead or syndicate investor, our third-quarter investment activity resulted in an additional $56.4 million of capital being invested in Connecticut, in a range of startup technology companies and scientific projects.”
About Connecticut Innovations
Connecticut Innovations (CI) is the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. To maximize company growth potential, CI provides venture capital and strategic support for early-stage technology companies, financial support for innovation and collaboration, and connections to its well-established network of partners and professionals. For more information, please visit www.ctinnovations.com.
Vice President of Marketing and Communications